Revenue and NOI grew 15% and 25% year-over-year in Q2 2026, driven by strong leased segment performance and the Dalata acquisition. Robust demand, stable booking trends, and a solid pipeline support continued growth, with RevPAR expected to rise 2–3% for the year.Based on Pandox AB Class B [PNDX_B…
Revenue and NOI grew 15% and 25% year-over-year in Q2 2026, driven by strong leased segment performance and the Dalata acquisition. Robust demand, stable booking trends, and a solid pipeline support continued growth, with RevPAR expected to rise 2–3% for the year.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.